Apollo Medical Holdings Inc (NASDAQ:AMEH) – Investment analysts at Dougherty & Co lowered their FY2019 earnings per share (EPS) estimates for Apollo Medical in a note issued to investors on Monday, November 11th. Dougherty & Co analyst G. Mannheimer now expects that the company will post earnings per share of $0.40 for the year, down from their prior estimate of $0.55. Dougherty & Co also issued estimates for Apollo Medical’s FY2020 earnings at $1.27 EPS.
Several other brokerages have also recently issued reports on AMEH. Zacks Investment Research raised Apollo Medical from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research report on Tuesday, October 8th. ValuEngine raised Apollo Medical from a “hold” rating to a “buy” rating in a research report on Monday, October 7th.
In other Apollo Medical news, insider Kenneth T. Sim acquired 6,000 shares of the stock in a transaction dated Friday, August 16th. The stock was purchased at an average price of $16.01 per share, with a total value of $96,060.00. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, insider Adrian Vazquez sold 84,800 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $20.02, for a total value of $1,697,696.00. Insiders bought a total of 14,000 shares of company stock valued at $227,840 in the last three months. Insiders own 11.83% of the company’s stock.
Several institutional investors have recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its position in shares of Apollo Medical by 113.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,733 shares of the company’s stock worth $28,000 after purchasing an additional 922 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Apollo Medical by 1,518.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,414 shares of the company’s stock valued at $57,000 after buying an additional 3,203 shares during the last quarter. Strs Ohio raised its stake in shares of Apollo Medical by 7.7% during the 2nd quarter. Strs Ohio now owns 15,400 shares of the company’s stock valued at $257,000 after buying an additional 1,100 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Apollo Medical by 52.4% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 19,822 shares of the company’s stock valued at $332,000 after buying an additional 6,816 shares during the last quarter. Finally, Commonwealth Equity Services LLC purchased a new position in shares of Apollo Medical during the 3rd quarter valued at about $387,000. 8.05% of the stock is owned by hedge funds and other institutional investors.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Featured Story: Monthly Dividend Stocks Can Provide Solid Income
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.